-
New consortium to develop PAT for cell and gene therapies
europeanpharmaceuticalreview
June 17, 2021
The Cell and Gene Therapy Catapult’s new consortium aims to accelerate therapeutic development by developing process analytical technologies (PAT) for cell and gene therapy manufacturing.
-
Cell and Gene Therapy Catapult forms consortium of over 20 organisations
pharmatimes
June 10, 2021
The Cell and Gene Therapy (CGT) Catapult has announced the formation of a consortium of over 20 organisations, which will aim to accelerate technology development in cell and gene therapy manufacturing.
-
Real-time bioprocess Raman analyser market to achieve significant growth
europeanpharmaceuticalreview
May 13, 2021
Market research shows the adoption of process analytical technologies and investment in pharma R&D and healthcare will drive growth in the real-time bioprocess Raman analyser market.
-
DIL reports a 115 per cent hike in PAT, releases financial report
expressbpd
May 29, 2019
The company recently released a consolidated financial report for Q4FY19 and FY19, registered a 34 per cent hike in net revenue
-
Siemens and Perceptive Engineering combining software solutions for the pharmaceutical industry
europeanpharmaceuticalreview
February 28, 2018
Siemens AG and Perceptive Engineering Ltd announce a partnership which offers Perceptive’s PharmaMV and Siemens Simatic Sipat software products closely integrated to provide a versatile solution for advanced control...
-
Tim Freeman's Powder Flow Feature: Embracing QbD and PAT
Tim Freeman
January 15, 2018
In recent decades, the pharmaceutical industry has employed innovative, cutting edge technology to undertake research, and to develop new drugs which deliver immense value to society.